pd-0325901 and Muscular-Diseases

pd-0325901 has been researched along with Muscular-Diseases* in 1 studies

Other Studies

1 other study(ies) available for pd-0325901 and Muscular-Diseases

Article	Year
Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse. Molecular genetics and metabolism, 2018, Volume: 123, Issue:4 Topics: Animals; Animals, Newborn; Benzamides; Diphenylamine; Extremities; Female; Homeodomain Proteins; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Muscular Diseases; MyoD Protein; Neurofibromatosis 1; Neurofibromin 1; ras Proteins; Signal Transduction	2018

Article

Year

Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse.

Molecular genetics and metabolism, 2018, Volume: 123, Issue:4

Topics: Animals; Animals, Newborn; Benzamides; Diphenylamine; Extremities; Female; Homeodomain Proteins; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Muscular Diseases; MyoD Protein; Neurofibromatosis 1; Neurofibromin 1; ras Proteins; Signal Transduction

2018